ArticlePDF Available

Education of Children With Human Immunodeficiency Virus Infection

Authors:

Abstract

This Policy Statement was retired April 2016 Treatment for human immunodeficiency virus (HIV) infection has enabled more children and youths to attend school and participate in school activities. Children and youths with HIV infection should receive the same education as those with other chronic illnesses. They may require special services, including home instruction, to provide continuity of education. Confidentiality about HIV infection status should be maintained with parental consent required for disclosure. Youths also should assent or consent as is appropriate for disclosure of their diagnosis.
AMERICAN ACADEMY OF PEDIATRICS
Committee on Pediatric AIDS
Education of Children With Human Immunodeficiency Virus Infection
ABSTRACT. Treatment for human immunodeficiency
virus (HIV) infection has enabled more children and
youths to attend school and participate in school activi-
ties. Children and youths with HIV infection should
receive the same education as those with other chronic
illnesses. They may require special services, including
home instruction, to provide continuity of education.
Confidentiality about HIV infection status should be
maintained with parental consent required for disclo-
sure. Youths also should assent or consent as is appro-
priate for disclosure of their diagnosis.
ABBREVIATIONS. HIV, human immunodeficiency virus; AIDS,
acquired immunodeficiency syndrome; CNS, central nervous sys-
tem; IDEA, Individuals With Disabilities Education Act; IFSP,
Individual Family Service Plan; IEP, Individualized Education
Program; AAP, American Academy of Pediatrics.
A
symptomatic children with human immuno-
deficiency virus (HIV) infection cannot be
distinguished from children without infec-
tion, and their educational opportunities should be
the same as other children. Children and youths with
HIV infection should not be excluded from school or
isolated within the school setting.
1
The spread of HIV
infection in school has not been documented, and
fear of its communicability must be allayed by ap-
propriate education of all school personnel. Partici-
pation in school provides a sense of normalcy for
children and adolescents with HIV infection and of-
fers opportunities for socialization that are important
to their development. School attendance promotes a
sense of belonging and reduces feelings of isolation
and rejection.
2
Those with HIV infection should par-
ticipate in all activities in school
3,4
to the extent that
their health permits, which includes a spectrum of
illness ranging from no symptoms to acquired im-
munodeficiency syndrome (AIDS). The need to ex-
clude children or youths with HIV infection from
school to protect their own health is unusual. Such a
decision should be made by the physician in consul-
tation with the child’s parent or caregiver.
HIV INFECTION AND DEVELOPMENTAL DELAY
The majority of children with HIV infection reach-
ing school age have normal cognitive function.
5–8
When symptoms develop in a child or adolescent
with HIV infection, central nervous system (CNS)
dysfunction can occur and cause a decrease in cog-
nitive function followed by a decline in academic
performance. Controlled clinical trials of antiretrovi-
ral therapy have shown improved neurodevelop-
mental function in symptomatic children.
9
Clinical
trials have also shown that with different antiretro-
viral therapy, CNS disease occurs at different rates,
indicating that optimal therapy can delay or prevent
CNS dysfunction.
9
The pediatrician should ensure
that initiation of developmental testing, evaluation of
CNS function, and appropriate referral of children
and youths to early intervention and special educa-
tion programs are the same as for children and
youths with other chronic illness that can require
such services. Physical education programs suitable
for the needs of the developmentally disabled or
chronically ill child, including those with HIV,
should be available.
FEDERAL DISABILITIES RIGHTS LAWS
Important protections exist for children and ado-
lescents with disabilities including HIV infection.
Several laws have been enacted to improve the avail-
ability of services in schools to assist children with
special health care needs to benefit optimally from
education.
10
The pediatrician should be familiar with
federal disabilities rights laws.
The Individuals With Disabilities Education Act
(IDEA), as reauthorized in 1997, is an outgrowth of
the Education of All Handicapped Children Act of
1975 (PL 94-142) and the Education of the Handi-
capped Act Amendments of 1986 (PL 99-457). IDEA
is a federal program that applies to children and
youths, ages 3 to 21 years, with developmental dis-
abilities and health impairments. It includes a provi-
sion to encourage states to expand opportunities for
children younger than 3 years who would be at risk
of having substantial developmental delay if they
did not receive early intervention services. IDEA
guarantees access to needed educational services and
provides for related services that may be required to
assist a child with a disability to benefit from special
education. Related services include transportation,
speech pathology, audiology, counseling, physical
therapy, and medical services for diagnosis. For per-
sons to be eligible for services under IDEA, their
condition, specified by the law, must have the poten-
tial to interfere with the educational process and
normal school performance and requires special ed-
ucational-related services.
For infants and toddlers birth to age 3 years with
disabilities, an annual Individual Family Service Plan
(IFSP), which is a component of IDEA, is developed
The recommendations in this statement do not indicate an exclusive course
of treatment or serve as a standard of medical care. Variations, taking into
account individual circumstances, may be appropriate.
PEDIATRICS (ISSN 0031 4005). Copyright © 2000 by the American Acad-
emy of Pediatrics.
1358 PEDIATRICS Vol. 105 No. 6 June 2000
by guest on February 7, 2016Downloaded from
to provide early intervention services. For children
and youths 3 to 21 years of age who require special
assistance, schools must prepare an Individualized
Education Program (IEP) and update it annually.
The IEP sets out a plan for special education and
related services to meet the child’s education goals.
The plan is designed by a multidisciplinary team that
includes the student’s parent(s), regular education
teacher, special education teacher, a representative of
the school administration, and, when appropriate,
the student. Ideally, the IEP team may include the
pediatrician and school nurse who are knowledge-
able about the student’s condition.
Section 504 of the Rehabilitation Act of 1973 is
available for any children or adolescents with special
health care needs and is applicable to those who do
not require special education instruction. It provides
the legal support for education in regular classes
with the use of supplementary services including
medical, nursing, psychological, physical, and occu-
pational therapies.
The Americans With Disabilities Act also provides
children and youths with disabilities certain protec-
tions by ensuring that schools and school programs
are available and accessible. For example, this act
mandates wheelchair-accessible buildings.
HIV MANAGEMENT IN THE SCHOOL SETTING
School personnel must be educated about HIV
disease and the potential long-term needs of the
infected student. All schools should have programs
for educating school personnel in standard precau-
tions and in recognition and management of medical
emergencies.
11,12
Students with chronic illnesses, in-
cluding HIV, may need medications administered
during the school day and established school proce-
dures should be used.
13
Confidentiality must be en-
sured. Under optimal circumstances and with paren-
tal consent (and student assent when appropriate),
the person(s) giving medications should be informed
of the student’s diagnosis and the side effects asso-
ciated with the drugs being taken. In the event that
the HIV diagnosis is not disclosed to school person-
nel, only the person(s) directly involved with the
provision of medication should be informed of the
student’s need for medication. Some medications
have special requirements, such as increased fluid
requirements. Appropriate access to fluid and bath-
room privileges should occur in response to physi-
cian requests.
HOME INSTRUCTION
Children and youths with symptomatic HIV infec-
tion or other chronic illnesses may be absent from
school and need home instruction sporadically until
the illness improves, or may require other special
school arrangements including permanent home in-
struction when the disease progresses. The policy on
home instruction published by the American Acad-
emy of Pediatrics (AAP) provides guidelines for ref-
erence, and schools must meet the requirements and
Section 504 of the Rehabilitation Act of 1973, the
Americans With Disabilities Act of 1990, and IDEA.
14
Home instruction should be provided promptly un-
der IDEA guidelines through the special education
coordinator working with the school medical advisor
and the student’s physician. The student’s physician
should help parents to facilitate the transition be-
tween school and other special arrangements, in-
cluding home instruction.
The student’s ability to continue his or her educa-
tion may diminish as disease progresses, and anger,
withdrawal, or depression can be present. The school
should continue to work with the medical system to
assist the family with counseling and emotional sup-
port. The school may also assist other students to a
better understanding of chronic illness and how to be
supportive of their classmates. Although family dis-
ruption and community rejection occur for students
with HIV infection, they are more common in fami-
lies who may need assistance from school mental
health personnel.
CONFIDENTIALITY
As long as disclosure of HIV infection can stigma-
tize students and families, confidentiality is impor-
tant. The need to safeguard the rights of the student
must be balanced with information essential to the
school to educate the students and faculty. The pri-
mary responsibility of the pediatrician is to care for
the child or youth and the family. Disclosure of the
child’s HIV status should be done only with the
consent of the parents and age-appropriate assent of
the student. Some families may not permit disclo-
sure, which should not prohibit the student from
attending school. Also, some HIV-infected children
who attend school have not had their conditions
diagnosed. An effective HIV/AIDS education pro-
gram for school personnel provides accurate infor-
mation about HIV infection and its transmission.
This education should provide reassurance to school
personnel and a more accepting environment for the
HIV-infected student.
11
EXPOSURE TO ILLNESS
Specific immunization requirements as recom-
mended by the AAP
2
are designed to be applicable to
HIV-infected children and youth. General immuni-
zation requirements for healthy children are also
available in the 1997 Red Book. These immunization
requirements are designed to protect all children and
adolescents and should be rigorously enforced to
reduce risk of exposure to vaccine-preventable ill-
nesses. Parents should be informed when measles or
varicella is occurring in the school setting.
1
Parents of
children and youths at increased risk of developing
severe illnesses should consult their physician.
CONCLUSION
Transmission of HIV from mother to child has
been significantly decreased with treatment, result-
ing in fewer HIV-infected children entering pre-
school and kindergarten. The advent of early aggres-
sive antiretroviral therapy has prolonged the number
of years that children can attend school,
15
enabling
many to continue their education through high
school and perhaps higher education. An under-
standing by school personnel of chronic illness man-
AMERICAN ACADEMY OF PEDIATRICS 1359
by guest on February 7, 2016Downloaded from
ifestations attributable to HIV infection is essential
for providing appropriate educational programs.
RECOMMENDATIONS
1. All children and youths with HIV infection
should have the same right as those without in-
fection to attend school and receive high-quality
educational services.
2. Children and youths with HIV infection should
have access to special education and other related
services in accord with their needs as the disease
progresses.
3. Mechanisms for administration of medications,
including confidential methods for HIV infection,
should be in place in all schools. This includes
appropriate facilitation of specific needs for fluids
or bathroom privileges.
4. Continuity of education must be ensured for chil-
dren and adolescents with HIV infection and en-
compasses the spectrum of traditional school,
medical day treatment programs, and home
schooling.
5. Confidentiality of HIV infection status should be
respected and maintained, with disclosure given
only with the consent of the parent(s) or legal
guardian(s) and age-appropriate assent of the stu-
dent.
6. The pediatrician/medical home provider should
maintain appropriate communication with the
school to facilitate the education of children in
their care.
Committee on Pediatric AIDS, 1999 –2000
Catherine M. Wilfert, MD, Chairperson
Mark W. Kline, MD, Chairperson-elect
Donna Futterman, MD
Peter L. Havens, MD
Susan King, MD
Lynne M. Mofenson, MD
Gwendolyn B. Scott, MD
Diane W. Wara, MD
Patricia N. Whitley-Williams, MD
Liaison Representatives
Mary Lou Lindegren, MD
Centers for Disease Control and Prevention
Consultant
Martin W. Sklaire, MD
Staff
Eileen Casey, MS
REFERENCES
1. American Academy of Pediatrics. HIV infection. In: Peter G, ed. 1997
Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove
Village, IL: American Academy of Pediatrics; 1997:279 –304
2. Centers for Disease Control and Prevention. Education and foster care
of children infected with HTLV III/lymphadenopathy-associated virus.
MMWR Morb Mortal Wkly Rep. 1985;34:517–521
3. American Academy of Pediatrics, Committee on Sports Medicine and
Fitness. Human immunodeficiency virus and other blood-borne viral
pathogens in the athletic setting. Pediatrics. 1999;104:1400 –1403
4. American Academy of Pediatrics, Committee on Pediatric AIDS and
Committee on Infectious Diseases. Issues related to human immunode-
ficiency virus transmission in schools, child care, medical settings, the
home, and community. Pediatrics. 1999;104:318 –324
5. Gay CL, Armstrong FD, Cohen D, et al. The effects of HIV on cognitive
and motor development in children born to HIV-seropositive women
with no reported drug use: birth to 24 months. Pediatrics. 1995;96:
1078–1082
6. Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby
A. Effect of perinatally acquired HIV on neurodevelopmental growth in
children during the first two years of life. Pediatrics. 1994;94:883–891
7. Chase C, Vibbert M, Pelton SI, et al. Early neurodevelopmental growth
in children with vertically transmitted HIV infection. Arch Pediatr Ado-
lesc Med. 1995;149:850 855
8. Tardieu M, Mayaux MJ, Seibel N, et al. Cognitive assessment of school-
age children infected with maternally transmitted human immunode-
ficiency virus type 1. Pediatrics. 1995;126:375–379
9. Englund J, Baker C, Raskino C, et al. Zidovudine, didanosine, or both as
the initial treatment for symptomatic HIV-infected children: AIDS Clin-
ical Trials Group (ACTG) Study 152 Team. N Engl J Med. 1997;336:
1704–1712
10. Bogden JF, Fraser K, Vega-Matos C, Ascroft J. Someone at School Has
AIDS: A Complete Guide to Education Policies Concerning HIV Infection.
Alexandria, VA: National Association of State Boards of Education;
1996:79 81
11. American Academy of Pediatrics, Committee on Pediatric AIDS. Hu-
man immunodeficiency virus/acquired immunodeficiency syndrome
education in schools. Pediatrics. 1998;101:933–935
12. American Academy of Pediatrics, Committee on School Health. Guide-
lines for urgent care in school. Pediatrics. 1990;86:999–1000
13. American Academy of Pediatrics, Committee on School Health. Guide-
lines for the administration of medication in school. Pediatrics. 1993;92:
499–500
14. American Academy of Pediatrics, Committee on School Health. Medi-
cally indicated home, hospital, and other non-school-based instruction.
AAP News. February 1992:19
15. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human
immunodeficiency virus disease in perinatally infected children: an
analysis from the Pediatric Spectrum Disease Project. Pediatrics. 1996;
97:710–716
1360 EDUCATION OF CHILDREN WITH HIV INFECTION
by guest on February 7, 2016Downloaded from
DOI: 10.1542/peds.105.6.1358
2000;105;1358Pediatrics
Committee on Pediatric AIDS
Education of Children With Human Immunodeficiency Virus Infection
Services
Updated Information &
/content/105/6/1358.full.html
including high resolution figures, can be found at:
References
/content/105/6/1358.full.html#ref-list-1
at:
This article cites 12 articles, 7 of which can be accessed free
Citations
/content/105/6/1358.full.html#related-urls
This article has been cited by 5 HighWire-hosted articles:
Subspecialty Collections
/cgi/collection/hiv:aids_sub
HIV/AIDS
/cgi/collection/infectious_diseases_sub
Infectious Disease
/cgi/collection/committee_on_pediatric_aids
Committee on Pediatric AIDS
following collection(s):
This article, along with others on similar topics, appears in the
Permissions & Licensing
/site/misc/Permissions.xhtml
tables) or in its entirety can be found online at:
Information about reproducing this article in parts (figures,
Reprints
/site/misc/reprints.xhtml
Information about ordering reprints can be found online:
rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Grove Village, Illinois, 60007. Copyright © 2000 by the American Academy of Pediatrics. All
and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk
publication, it has been published continuously since 1948. PEDIATRICS is owned, published,
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on February 7, 2016Downloaded from
DOI: 10.1542/peds.105.6.1358
2000;105;1358Pediatrics
Committee on Pediatric AIDS
Education of Children With Human Immunodeficiency Virus Infection
/content/105/6/1358.full.html
located on the World Wide Web at:
The online version of this article, along with updated information and services, is
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2000 by the American Academy
published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
publication, it has been published continuously since 1948. PEDIATRICS is owned,
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on February 7, 2016Downloaded from
Article
Full-text available
Introduction: Engaging adolescents in HIV care and research promotes the development of interventions tailored to their unique needs. Guidelines generally require parental permission for adolescents to receive HIV care/testing or participate in research, with exceptions. Nevertheless, parental permission requirements can restrict adolescent involvement in care and research. To better appreciate prospects for policy reform, we sought to understand the perspectives of stakeholders involved in the development, review and implementation of policies related to adolescents living with HIV. Methods: Semi-structured individual interviews (IDIs) were conducted from October 2019 to March 2020 with 18 stakeholders with expertise in the (1) development of policy through membership in the Law Society of Kenya or work as a health policy official; (2) review of policy through ethics review committee service; or (3) implementation of policy through involvement in adolescent education. IDIs were conducted in English by Kenyan social scientists, audio-recorded and transcribed verbatim. We used thematic analysis to identify themes around how policies can be reformed to improve adolescent engagement in HIV care and research. Results: Our analysis identified three major themes. First, policies should be flexible rather than setting an age of consent. Stakeholders noted that adolescents' capacity for engagement in HIV care and research depended on context, perceived risks and benefits, and "maturity"-and that age was a poor proxy for the ability to understand. Second, policies should evolve with changing societal views about adolescent autonomy. Participants recognized a generational shift in how adolescents learn and mature, suggesting the need for a more frequent review of HIV care and research guidelines. Third, adults should empower adolescent decision-making. Stakeholders felt that caregivers can gradually involve adolescents in decision-making to equip them to gain ownership over their health and lives, improving their confidence and capacity. Conclusions: Revising relevant laws to consider context, alternative measures of maturity, and evolving societal views about adolescence, along with supporting caregivers to assist in developing adolescent autonomy may promote more equitable and representative participation of adolescents in HIV care and research. Additional research should explore how to support caregivers and other adults to empower adolescents and improve stakeholder engagement in a more routine process of policy reform.
Article
Full-text available
Current recommendations of the American Academy of Pediatrics (AAP) for infection control practices to prevent transmission of blood-borne pathogens, including human immunodeficiency virus (HIV) in hospitals, other medical settings, schools, and child care facilities, are reviewed and explained. Hand-washing is essential, whether or not gloves are used, and gloves should be used when contact with blood or blood-containing body fluids may occur. In hospitalized children, the 1996 recommendations of the Centers for Disease Control and Prevention (CDC) should be implemented as modified in the 1997 Red Book. The generic principles of Standard Precautions in the CDC guidelines generally are applicable to children in all health care settings, schools, child care facilities, and the home. However, gloves are not required for routine changing of diapers or for wiping nasal secretions of children in most circumstances. This AAP recommendation differs from that in the CDC guidelines. Current US Public Health Service guidelines for the management of potential occupational exposures of health care workers to HIV are summarized. As previously recommended by the AAP, HIV-infected children should be admitted without restriction to child care centers and schools and allowed to participate in all activities to the extent that their health and other recommendations for management of contagious diseases permit. Because it is not required that the school be notified of HIV infection, it may be helpful if the pediatrician notify the school that he or she is operating under a policy of nondisclosure of infection with blood-borne pathogens. Thus, it is possible that the pediatrician will not report the presence of such infections on the form. Because HIV infection occurs in persons throughout the United States, these recommendations for prevention of HIV transmission should be applied universally.
Article
Full-text available
The human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic has grown during the past 15 years. Education remains a critical component of our efforts to prevent HIV infection/AIDS in school children and young adults. To accomplish this goal, school personnel should receive updated information about HIV infection/AIDS so that accurate teaching on this topic can be included in the K-12 health education curriculum. Informed pediatricians and nurses can serve as important resources for school health services and administration to provide current information for the curriculum. Each community should have a school health advisory committee that enlists community support and provides input to health education programs in schools.
Objective: To examine mental and motor development in children with vertically transmitted human immunodeficency virus (HIV) infection in the first 30 months of life.Design: Prospective longitudinal study comparing two groups: children with HIV infection and HIV-exposed but uninfected children.Setting: Pediatric Immunodeficiency Clinic at Boston (Mass) City Hospital, Boston University Medical Center.Study Participants: Twenty-four children with vertically transmitted HIV infection and 27 children who were born to HIV-infected mothers and became HIV negative served as controls. Socioeconomic status, gestational age, and prenatal drug exposure were comparable in the two groups.Measurements/Results: Using the Bayley Scales of Infant Development, all children were assessed at least once between 4 and 16 months and again between 17 and 30 months of age. Individual mean mental and motor scores were calculated for the early and later age span. Motor development in the infected group was delayed in comparison to the seroreverter group in both age spans and remained stable in both groups over time. Mental development was comparable in the two groups at 4 to 17 months, but HIV infection was associated with delay in mental development at 17 to 30 months of age.Conclusion: Early and persistent delay in motor development and deceleration in mental development in late infancy distinguishes many children who are HIV infected from exposed but uninfected children, but there is significant variability in early neurodevelopmental outcome among children with HIV infection.(Arch Pediatr Adolesc Med. 1995;149:850-855)
Article
This Policy Statement was retired September 2019 Because athletes and the staff of athletic programs can be exposed to blood during athletic activity, they have a very small risk of becoming infected with human immunodeficiency virus, hepatitis B virus, or hepatitis C virus. This statement, which updates a previous position statement of the American Academy of Pediatrics,1 discusses sports participation for athletes infected with these pathogens and the precautions needed to reduce the risk of infection to others in the athletic setting. Each of the recommendations in this statement is dependent upon and intended to be considered with reference to the other recommendations in this statement and not in isolation.
Article
Zidovudine has been the drug of choice for the initial treatment of symptomatic children infected with the human immunodeficiency virus (HIV). This trial was designed to assess the efficacy and safety of treatment with zidovudine alone as compared with either didanosine alone or combination therapy with zidovudine plus didanosine. In this multicenter, double-blind study, symptomatic HIV-infected children 3 months through 18 years of age were stratified according to age (<30 months or > or =30 months) and randomly assigned to receive zidovudine, didanosine, or zidovudine plus didanosine. The primary end point was length of time to death or to progression of HIV disease. Of the 831 children who could be evaluated, 92 percent had never received antiretroviral therapy and 90 percent had acquired HIV perinatally. An interim analysis (median follow-up, 23 months) showed a significantly higher risk of HIV-disease progression or death in patients receiving zidovudine alone than in those receiving combination therapy (relative risk, 0.61; 95 percent confidence interval, 0.42 to 0.88; P=0.007). The study arm with zidovudine alone was stopped and unblinded; the other two treatment arms were continued. At the end of the study, didanosine alone had an efficacy similar to that of zidovudine plus didanosine (median follow-up, 32 months) (relative risk of disease progression or death, 0.98; 95 percent confidence interval, 0.70 to 1.37; P=0.91). A significantly lower risk of anemia or neutropenia was seen in patients receiving didanosine alone (P=0.036). In symptomatic HIV-infected children, treatment with either didanosine alone or zidovudine plus didanosine was more effective than treatment with zidovudine alone. The efficacy of didanosine alone was similar to that of the combination therapy and was associated with less hematologic toxicity.
Article
This study documents delays in the mental and motor functioning of infants perinatally infected with human immunodeficiency virus (HIV) while controlling for confounding effects of prenatal drug exposure, ethnicity, socioeconomic status, and maternal separation and death. The cognitive and motor development of 126 infants born to nondrug-using, HIV-seropositive Haitian women was assessed at 3-month intervals through 24 months of age using the Bayley Scales of Infant Development. By 18 months of age, 28 of the infants were diagnosed as HIV-infected, and the 98 uninfected infants served as a control group. The infected and uninfected infants did not differ with respect to mean gestational age, birth weight, ethnicity, or rates of maternal separation and death. By 3 months of age, the mean mental and motor scores of the infected infants were significantly lower than those of the uninfected controls. Furthermore, the initial differences between the two groups increased over time, as many of the infected infants became increasingly delayed. Although the infected infants tended to perform more poorly than the uninfected infants, nearly one third of the infected infants exhibited relatively normal cognitive development and half demonstrated relatively normal motor development. Over the first 24 months of life, the mean rate of development of HIV-infected infants is significantly slower than that of noninfected infants born to seropositive mothers. This occurs even when the effects are not confounded with those of prenatal drug exposure.
To examine mental and motor development in children with vertically transmitted human immunodeficiency virus (HIV) infection in the first 30 months of life. Prospective longitudinal study comparing two groups: children with HIV infection and HIV-exposed but uninfected children. Pediatric Immunodeficiency Clinic at Boston (Mass) City Hospital, Boston University Medical Center. Twenty-four children with vertically transmitted HIV infection and 27 children who were born to HIV-infected mothers and became HIV negative served as controls. Socioeconomic status, gestational age, and prenatal drug exposure were comparable in the two groups. Using the Bayley Scales of Infant Development, all children were assessed at least once between 4 and 16 months and again between 17 and 30 months of age. Individual mean mental and motor scores were calculated for the early and later age span. Motor development in the infected group was delayed in comparison to the seroreverter group in both age spans and remained stable in both groups over time. Mental development was comparable in the two groups at 4 to 17 months, but HIV infection was associated with delay in mental development at 17 to 30 months of age. Early and persistent delay in motor development and deceleration in mental development in late infancy distinguishes many children who are HIV infected from exposed but uninfected children, but there is significant variability in early neurodevelopmental outcome among children with HIV infection.